公开(公告)号：US20200231939A1

公开(公告)日：2020-07-23

申请号：US16230114

申请日：2018-12-21

Applicant: The University of Warwick

Inventor： Nigel J. Dimmock ,  Andrew J. Easton

IPC: C12N7/00 ,  C12N7/04 ,  C12Q1/70

Abstract: The invention relates to defective interfering viruses and defective interfering virus RNAs that are effective as antiviral agents. The invention also relates to methods for identifying defective interfering virus RNAs that can be used as effective antiviral agents.

公开(公告)号：US11339374B2

公开(公告)日：2022-05-24

申请号：US16230114

申请日：2018-12-21

Applicant: The University of Warwick

Inventor： Nigel J. Dimmock ,  Andrew J. Easton

IPC: C12N7/00 ,  C12Q1/70 ,  C12N7/04

Abstract: The invention relates to defective interfering viruses and defective interfering virus RNAs that are effective as antiviral agents. The invention also relates to methods for identifying defective interfering virus RNAs that can be used as effective antiviral agents.

公开(公告)号：US20160333321A1

公开(公告)日：2016-11-17

申请号：US15111615

申请日：2015-01-16

Applicant: THE UNIVERSITY OF WARWICK

Inventor： Nigel J. Dimmock ,  Andrew J. Easton

IPC: C12N7/00 ,  C12Q1/70

CPC classification number: C12N7/00 ,  C12N7/045 ,  C12N2760/16132 ,  C12N2760/16162 ,  C12Q1/701

Abstract: The invention relates to defective interfering viruses and defective interfering virus RNAs that are effective as antiviral agents. The invention also relates to methods for identifying defective interfering virus RNAs that can be used as effective antiviral agents.

Abstract translation: 本发明涉及作为抗病毒剂有效的缺陷性干扰病毒和有缺陷的干扰性病毒RNA。 本发明还涉及用于鉴定可用作有效的抗病毒剂的有缺陷的干扰性病毒RNA的方法。